Fierce opposition to top pharmaceutical companies’ distribution margin cuts

The pharmaceutical distribution industry has strongly opposed to the Korean top pharmaceutical companies’ recent drug distribution margin cuts.

According to the industry concerned, it was told a Korean pharmaceutical company informed its client pharmaceutical distribution companies to cut distribution margins from current 8% to 5% for a multinational pharmaceutical company’s products.

The pha...